Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Novus Detox Center Alerts Police and EMS to Risk of Accidental Fentanyl Overdose
  • USA - English


News provided by

iReachCompany

Nov 21, 2017, 11:17 ET

Share this article

Share toX

Share this article

Share toX


NEW PORT RICHEY, Fla., Nov. 21, 2017 /PRNewswire-iReach/ -- Two law enforcement officers exhibited signs of an overdose after accidental contact with fentanyl earlier this year;(1) meanwhile, fentanyl-related deaths are skyrocketing—in a single year, synthetic opioid overdose fatalities have more than doubled,(2) and fentanyl now accounts for more than half of opioid overdose deaths in many states.(3) Novus Detox Center, a preeminent Florida-based drug treatment provider, aims to increase awareness of the risks of accidental fentanyl exposure, advising police and other first responders to take the necessary precautions.

In May 2017, sheriff's deputy and paramedic Kevin Phillips experienced overdose symptoms after searching a Maryland home for drugs; in Ohio, patrolman Chris Green passed out after brushing white powder from his uniform following a drug-related traffic stop. Both officers suffered accidental exposure to fentanyl and had to be revived with the overdose-reversing drug Narcan.(1) The U.S. Drug Enforcement Administration (DEA) estimates that fentanyl is 30 to 50 times more potent than heroin and 50 to 100 times more potent than morphine. According to the DEA, just 2 to 3 milligrams of fentanyl—an amount equivalent to five to seven grains of table salt—is capable of causing respiratory depression and arrest, and potentially even death, if it is ingested, inhaled, or absorbed through the skin or eyes.(4)

Quote Text

Post this

The growing prevalence of fentanyl has translated to rising deaths. Provisional counts by the Centers for Disease Control and Prevention (CDC) show that fatalities linked to synthetic opioids—including fentanyl—rose from 9,945 to 20,145 between January 2016 and January 2017.(2) Another new CDC report revealed that fentanyl was detected in at least half of all opioid overdose deaths in seven of the 10 states examined; in total, fentanyl was linked to 56.3% of all opioid-related fatalities recorded in the six-month, 10-state study.(3)

"Fentanyl poses an extreme hazard to the public, both to those who ingest the drug and others who inadvertently come into contact with it," warned Kent Runyon, Vice President of Community Relations for Novus Detox Center. "Counterfeit prescription opioid pills often contain fentanyl, and it is increasingly being mixed with heroin and other street drugs to increase potency and decrease cost. Police, firefighters and emergency medical technicians face severe health risks if they unknowingly come into contact with fentanyl, which can occur when investigating drug cases or treating overdose victims."

The recent spate of accidental overdoses led the DEA to publish a fentanyl briefing guide for first responders.(4) Runyon advises anyone employed in law enforcement, emergency response or healthcare to review the information and recommendations outlined in the document. Responders should take precautions if they encounter overdose victims exhibiting cyanosis or respiratory arrest, evidence of loose powders or nasal spray bottles, or parcels postmarked from China, particularly when multiple overdoses are occurring within a small geographic area over a period of two to three days. The guide highlights the appropriate safety protocols for dealing with fentanyl, such as contacting officials with hazardous materials training and donning appropriate personal protective equipment.

"Law enforcement officers and emergency-response personnel must be proactive in protecting themselves against the growing threat posed by fentanyl," said Runyon. "Our best chance of defeating this scourge is to identify individuals with opioid use disorders and help them obtain appropriate treatment. As long as there is a demand for opioids within a community, fentanyl will continue to be used by dealers seeking to maximize profits. If we focus on getting current users into opioid detox and treatment programs, drug dealers will lose their customer base—which will hopefully put an end to the current fentanyl crisis."

Novus provides medically supervised opioid treatment programs that feature individualized care and an emphasis on sustainable sobriety. In addition to its 31-bed inpatient treatment center near Tampa Bay, Novus will soon be opening a new 41-bed detox facility in West Palm Beach. For more information on Novus Detox Center and its opioid treatment programs, visit https://novusdetox.com.

About Novus Detox Center:

Novus Detox Center is soon to be operating two inpatient medical detox facilities that are licensed by the Florida Department of Children and Families and have earned The Joint Commission's Gold Seal of Approval for Behavioral Health Care Accreditation. Renowned for its pioneering approach to Sustainable Sobriety™, Novus provides safe and effective alcohol and drug detox programs that combine next-generation treatment protocols, 24/7 medical supervision and integrated, individualized care. By conditioning the body and mind to re-imagine a fulfilling, drug-free future, Novus empowers patients on their journey to recovery and creates a solid foundation for long-term success. Novus is committed to leading the way in patient experience, both as a detoxification expert and a supportive partner in ongoing health and wellness, and is dedicated to pushing industry standards forward. The original Florida detox facility is located in New Port Richey (outside Tampa) and another is soon to open in West Palm Beach; both feature a wide range of amenities, delicious and healthy meals, and a relaxing, spa-like environment to ensure the withdrawal process is as stress-free and comfortable and as possible. For more information on Novus' medically supervised detox programs, visit https://novusdetox.com.

  •      Noble, Andrea. "Cops answering opioid-overdose calls are at risk of accidental fentanyl overdose, DEA warns"; The Washington Times; June 6, 2017. washingtontimes.com/news/2017/jun/6/police-responding-opioid-cases-risk-accidental-ove/
  •      Centers for Disease Control and Prevention (CDC). Provisional Counts of Drug Overdose Deaths; August 6, 2017. cdc.gov/nchs/data/health_policy/monthly-drug-overdose-death-estimates.pdf
  •      O'Donnell, Julie K; John Halpin; et al. "Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016"; Morbidity and Mortality Weekly Report; November 3, 2017. cdc.gov/mmwr/volumes/66/wr/mm6643e1.htm
  •      U.S. Drug Enforcement Administration (DEA). Fentanyl: A Briefing Guide for First Responders; June 2017. dea.gov/druginfo/Fentanyl_BriefingGuideforFirstResponders_June2017.pdf

Media Contact: Karla Jo Helms, JoTo PR, 888-202-4614, [email protected]

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE Novus Medical Detox

iReach LastName, iReachCompany, 111-222-3333, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.